MPS Pharmaa Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 232123,
    "name": "MPS Pharmaa",
    "stock_name": "MPS Pharmaa",
    "full_name": "MPS Pharmaa Ltd",
    "name_url": "stocks-analysis/mps-pharmaa",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.85",
    "chg": -0.23,
    "chgp": "-11.06%",
    "dir": -1,
    "prev_price": "2.08",
    "mcapval": "4.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531686,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE537C01019",
    "curr_date": "Dec 29",
    "curr_time": "",
    "bse_nse_vol": "1.25 k",
    "exc_status": "Active",
    "traded_date": "Dec 29, 2025",
    "traded_date_str": "2025 12 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mps-pharmaa-232123-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "MPS Pharmaa Ltd Opens with Sharp Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mps-pharmaa-ltd-opens-with-sharp-gap-down-amid-market-concerns-3773747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MPSPharmaaLtd_gapdown_3773747.png",
        "date": "2025-12-29 18:00:15",
        "description": "MPS Pharmaa Ltd witnessed a significant gap down at market open today, reflecting heightened market concerns following overnight developments. The stock opened at a new 52-week low of Rs. 1.76, marking a steep decline of 15.38% from its previous close, signalling a weak start for the pharmaceutical company amid sector underperformance."
      },
      {
        "title": "When is the next results date for MPS Pharmaa?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mps-pharmaa-3694003",
        "imagepath": "",
        "date": "2025-11-12 23:17:40",
        "description": "The next results date for MPS Pharmaa is scheduled for 14 November 2025...."
      },
      {
        "title": "How has been the historical performance of MPS Pharmaa?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-mps-pharmaa-3623873",
        "imagepath": "",
        "date": "2025-10-15 22:38:37",
        "description": "Answer:\nThe historical performance of MPS Pharmaa shows a consistent decline in key financial metrics over the years, particularly from 2020 to 2025.\n\nBreakdown:\nMPS Pharmaa's share capital has remained stable at Rs 19.11 crore from 2020 to 2025, while total reserves have worsened, moving from -10.75 crore in 2020 to -18.03 crore in 2025. Shareholder's funds have also decreased significantly, dropping from Rs 8.36 crore in 2020 to just Rs 1.08 crore in 2025. The company has maintained no long-term borrowings throughout this period, indicating a lack of debt financing. However, total liabilities have decreased from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, primarily due to a reduction in current liabilities. The total assets have similarly declined from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, with a notable drop in net current assets, which have remained negative, indicating ongoing liquidity..."
      },
      {
        "title": "MPS Pharmaa Faces Evaluation Adjustment Amid Financial Strain and Low Investor Confidence",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mps-pharmaa-stock-downgraded-to-strong-sell-amid-financial-concerns-3606060",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MPSPharmaa_mojoScore_3606060.png",
        "date": "2025-10-09 08:04:19",
        "description": "MPS Pharmaa, a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently experienced a score revision due to a decline in its quality grade. The company faces financial challenges, including negative net debt and a low return on capital employed, alongside bearish technical indicators and low institutional holding."
      },
      {
        "title": "MPS Pharmaa Faces Quality Grade Downgrade Amidst Financial Challenges and Market Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mps-pharmaa-downgraded-to-below-average-quality-grade-amid-financial-challenges-3605514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MPSPharmaa_qualitydot_3605514.png",
        "date": "2025-10-09 08:00:12",
        "description": "MPS Pharmaa, a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently adjusted its quality evaluation, revealing negative financial metrics such as a -16.00% ROCE and a low institutional holding of 0.58%. Its performance lags behind peers, with significant declines over the past decade."
      },
      {
        "title": "How has been the historical performance of MPS Pharmaa?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-mps-pharmaa-3604877",
        "imagepath": "",
        "date": "2025-10-08 22:37:11",
        "description": "Answer:\nThe historical performance of MPS Pharmaa shows a declining trend in key financial metrics over the years, particularly from 2018 to 2025.\n\nBreakdown:\nMPS Pharmaa's net sales peaked at 4.00 Cr in March 2018 but have since declined to 0.00 Cr by March 2025. Other operating income also saw a decrease, dropping from 0.10 Cr in March 2018 to 0.00 Cr in March 2025. Total operating income followed a similar trend, falling from 4.09 Cr in March 2018 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was highest in March 2017 at 9.72 Cr and has since decreased to 0.76 Cr in March 2025. Operating profit (PBDIT) has remained negative throughout this period, with the most significant loss recorded in March 2017 at -6.88 Cr, improving slightly to -0.71 Cr by March 2025. Profit before tax and profit after tax also reflect losses, with the latter reaching -0.90 Cr in March 2025. Th..."
      }
    ],
    "total": 13,
    "sid": "232123",
    "stock_news_url": "https://www.marketsmojo.com/news/mps-pharmaa-232123"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Amendment Thereof",
      "datetime": "19-Nov-2025",
      "details": "PFA intimation under Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Oct-2025",
      "details": "Submission of 74(5) certificate under SEBI (DP) Reg 2018 for the quarter ended 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Investor Complaints For The Quarter Ended 30Th September 2025",
      "datetime": "14-Oct-2025",
      "details": "Submission of statement of investor complaint for the quarter ended 30.09.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

MPS Pharmaa Ltd Opens with Sharp Gap Down Amid Market Concerns

2025-12-29 18:00:15

MPS Pharmaa Ltd witnessed a significant gap down at market open today, reflecting heightened market concerns following overnight developments. The stock opened at a new 52-week low of Rs. 1.76, marking a steep decline of 15.38% from its previous close, signalling a weak start for the pharmaceutical company amid sector underperformance.

When is the next results date for MPS Pharmaa?

2025-11-12 23:17:40

The next results date for MPS Pharmaa is scheduled for 14 November 2025....

How has been the historical performance of MPS Pharmaa?

2025-10-15 22:38:37

Answer: The historical performance of MPS Pharmaa shows a consistent decline in key financial metrics over the years, particularly from 2020 to 2025. Breakdown: MPS Pharmaa's share capital has remained stable at Rs 19.11 crore from 2020 to 2025, while total reserves have worsened, moving from -10.75 crore in 2020 to -18.03 crore in 2025. Shareholder's funds have also decreased significantly, dropping from Rs 8.36 crore in 2020 to just Rs 1.08 crore in 2025. The company has maintained no long-term borrowings throughout this period, indicating a lack of debt financing. However, total liabilities have decreased from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, primarily due to a reduction in current liabilities. The total assets have similarly declined from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, with a notable drop in net current assets, which have remained negative, indicating ongoing liquidity...

MPS Pharmaa Faces Evaluation Adjustment Amid Financial Strain and Low Investor Confidence

2025-10-09 08:04:19

MPS Pharmaa, a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently experienced a score revision due to a decline in its quality grade. The company faces financial challenges, including negative net debt and a low return on capital employed, alongside bearish technical indicators and low institutional holding.

MPS Pharmaa Faces Quality Grade Downgrade Amidst Financial Challenges and Market Pressures

2025-10-09 08:00:12

MPS Pharmaa, a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently adjusted its quality evaluation, revealing negative financial metrics such as a -16.00% ROCE and a low institutional holding of 0.58%. Its performance lags behind peers, with significant declines over the past decade.

How has been the historical performance of MPS Pharmaa?

2025-10-08 22:37:11

Answer: The historical performance of MPS Pharmaa shows a declining trend in key financial metrics over the years, particularly from 2018 to 2025. Breakdown: MPS Pharmaa's net sales peaked at 4.00 Cr in March 2018 but have since declined to 0.00 Cr by March 2025. Other operating income also saw a decrease, dropping from 0.10 Cr in March 2018 to 0.00 Cr in March 2025. Total operating income followed a similar trend, falling from 4.09 Cr in March 2018 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was highest in March 2017 at 9.72 Cr and has since decreased to 0.76 Cr in March 2025. Operating profit (PBDIT) has remained negative throughout this period, with the most significant loss recorded in March 2017 at -6.88 Cr, improving slightly to -0.71 Cr by March 2025. Profit before tax and profit after tax also reflect losses, with the latter reaching -0.90 Cr in March 2025. Th...

View All News